Lapatinib Terminated Phase 1 Trials for HER2 Positive / Failure or Contraindication of Trastuzumab Therapy / First or Second Line Therapy / Metastatic Breast Cancer (MBC) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01238029Dose Finding Study for Combination of Capecitabine, Lapatinib and Vinorelbine in Metastatic Breast Cancer